Skip to content
Biodatica
Start free

TEMPLE UNIV OF THE COMMONWEALTH

PHILADELPHIA, PA

Grant-only
Sign in to watch

What changed

NIH R01 · $0.6M · MyomiR-499, Exosomes and Endothelial and Endothelial Progenitor Cells dysfunction in Diabetes

Mar 2025Grant renewalMar 24, 2025Source filing (opens the source filing in a new tab)

Momentum

16no change

Momentum 16 out of 100, unchanged since the last recompute.

Little recent filing activity, or the events on file have decayed.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R01 · $617k · non-dilutive

    Apr 1, 2024

    TEMPLE UNIV OF THE COMMONWEALTH · PI KISHORE, RAJ · NHLBI · award ends Mar 31, 2028 · MyomiR-499, Exosomes and Endothelial and Endothelial Progenitor Cells dysfunction in Diabetes

    NIH RePORTER · NIH RePORTER 11051878 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources